Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;334:169-170 (27 January), doi:10.1136/bmj.39101.381655.1F
Further to the systematic review of Oliver et al on strategies to prevent falls and fractures in hospitals and care homes,1 evidence from a recent clinical trial by colleagues and myself shows that clinical medication review by a pharmacist of care home residents and their treatment is associated with a substantial and significant (P<0.0001) reduction in the number of falls from 1.3 to 0.8 falls per patient in six months (secondary outcome).2 Since very little else has been shown to reduce the high incidence of falls in care home residents, this evidence is of particular value.
Our intervention also led to an increase in the number of drug changes per subject (2.4 versus 3.1, P<0.0001), but no difference in the number of general practitioner consultations, cognitive state, activities of daily living, or the number or cost of prescribed drugs. The reduction in hospitalisations did not reach significance.
Arnold G Zermansky, honorary senior research fellow
1 Pharmacy Practice and Medicines Management Group, Healthcare Studies, University of Leeds LS2 9JT zermansky@btinternet.com